Search & Analyze

Sun Pharma Advanced Research Company Ltd.

176.90−6.35 (−3.47%)

BSE · 30 Oct, 4:01 PM

: ₹5,740.79 Cr
: 3.62
: 54,399
: ₹183.50 - ₹175.40
: ₹289.00 - ₹108.20

Sun Pharma Advanced Research Company Ltd. (SPARC) share price closed at ₹176.90 on the BSE on Friday, October 30, 2026, down by 3.47% from its of ₹183.25. In that session SPARC reached a of 183.50 and of 175.40. The for the session was 178.33. The stands at 193.28 and is at 177.62. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹182.60

₹183.25

₹178.33

₹193.28

Price 8.47% below

₹177.62

Price 0.41% below

Key Fundamentals

: 5,740.79 Cr₹5.74 Thousand Crore
: 48.82
: 3.62
: 4.36
: 40.62
: 1,642.30 Cr₹1.64 Thousand Crore
: 0.00 %
Sector
Industry: Business Support
: 276.89
: 0.42

Industry Comparison

Ratio	Company	Sector
	3.62	21.01
	0.42	0.09
	4.36	2.39
	2.47	1.99
	0.00 %	0.00 %
Operating Margin	85.08 %	18.10 %

Sector figures are the median of 58 listed Business Services companies.

Peer Comparison

Name
PRIME FOCUS PFOCUS	284.60	194.02	22,163.90	0.00	-45.78	-141.44%	1,266.82	23.82%	14.29
SAGILITY SAGILITY	42.00	19.16	19,661.58	0.36	284.21	13.31%	2,032.10	22.53%	13.82
IGIL IGIL	397.55	25.81	17,180.51	1.26	185.84	43.18%	398.02	31.04%	77.00
SYNGENE SYNGENE	401.90	87.33	16,223.46	0.31	32.20	-52.01%	832.70	-8.55%	9.48
INDGN INDGN	587.65	34.45	14,164.43	0.38	112.30	9.99%	1,122.30	39.55%	18.92
HORIZONIND HORIZONIND	43.80		12,627.11	0.00	13.93	118.32%	214.99	29.88%	3.32
NESCO LTD NESCO	988.80	17.33	6,967.08	0.71	105.21	-11.52%	228.44	-4.49%	19.23
Sun Pharma Advanced Research Company Ltd. SPARC	176.90	3.62	5,740.79	0.00	-20.78	59.94%	39.92	314.11%	163.94

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	16.56	16.81	12.86	14.91	27.19	9.64	7.86	8.45	1,853.22	39.92
Expenses	122.39	110.17	115.77	88.60	80.37	61.72	73.58	65.09	80.02	73.92
	-105.83	-93.36	-102.91	-73.69	-53.18	-52.08	-65.72	-56.64	1,773.20	-34.00
	-639.07%	-555.38%	-800.23%	-494.23%	-195.59%	-540.25%	-836.13%	-670.30%	95.68%	-85.17%
	4.40	1.56	0.04	0.19	0.00	9.14	0.01	-12.36	1.80	23.66
Interest	0.91	0.56	1.14	2.80	4.54	6.19	7.52	8.78	11.64	8.13
	3.07	3.14	3.16	3.14	2.95	2.68	2.56	2.57	2.40	2.20
	-105.41	-95.50	-107.17	-79.44	-60.67	-51.81	-75.79	-80.35	1,760.96	-20.67
	-0.36%	-0.42%	-0.15%	-0.09%	1.48%	-0.12%	-0.08%	-0.09%	-0.02%	-0.53%
	-105.79	-95.90	-107.33	-79.51	-59.77	-51.87	-75.85	-80.42	1,761.34	-20.78
	-3.26	-2.96	-3.31	-2.45	-1.84	-1.60	-2.34	-2.48	54.28	-0.64

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
Operating Income	238.78	75.55	71.77	1,879.17
Operating Income (Net)	238.78	75.55	71.77	1,879.17
EXPENDITURE :
Power & Fuel Cost	5.75	6.14	6.33	6.26
Employee Cost	107.00	141.84	153.58	118.02
Operating Expenses	180.31	140.23	114.52	56.00
General and Administration Expenses	154.91	182.20	115.92	88.01
Miscellaneous Expenses	4.87	7.23	4.55	12.11
	452.84	477.64	394.90	280.40
Operating Profit (Excl OI)	-214.06	-402.10	-323.14	1,598.76
	10.88	29.47	1.79	10.95
	-203.18	-372.63	-321.35	1,609.72
Interest	7.63	1.69	9.04	34.13
PBDT	-210.81	-374.32	-330.39	1,575.58
	11.77	12.51	12.39	10.21
Profit Before Taxation & Exceptional Items	-222.58	-386.83	-342.78	1,565.37
Exceptional Income / Expenses				-12.36
	-222.58	-386.83	-342.78	1,553.01
Provision for Tax		0.38	-0.27	-0.19
	-222.58	-387.21	-342.51	1,553.20
Extra items			0.00	0.00
Consolidated Net Profit	-222.58	-387.21	-342.51	1,553.20
Profit Balance B/F	-1,370.58	-1,591.81	-1,978.84	-2,321.60
Appropriations	-1,593.17	-1,979.03	-2,321.35	-768.40
	-6.86	-11.93	-10.55	47.86
Adjusted EPS	-6.86	-11.93	-10.55	47.86

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	32.45	32.45	32.45	32.45
Total Reserves	480.32	93.30	-249.40	1,306.37
Reserve excluding Revaluation Reserve	480.32	93.30	-249.40	1,306.37
	512.78	125.76	-216.95	1,338.83
Unsecured Loans			100.00
Deferred Tax Assets / Liabilities		-1.26	-2.31	-2.27
Other Long Term Liabilities	130.27	118.18	70.57	65.61
Long Term Provisions	8.14	6.05	7.68	12.34
Total Non-Current Liabilities	138.41	122.97	175.93	75.68
Trade Payables	148.25	142.29	113.92	97.15
Other Current Liabilities	24.15	61.88	94.24	87.96
Short Term Borrowings	0.05	47.00	158.19	556.14
Short Term Provisions	6.49	13.89	7.89	12.85
Total Current Liabilities	178.95	265.06	374.24	754.11
Total Liabilities	830.13	513.78	333.22	2,168.61
Gross Block	146.22	157.14	158.11	143.99
Less: Accumulated Depreciation	40.47	49.60	59.35	58.67
	105.75	107.53	98.76	85.32
	1.87	1.27	0.56	0.50
Long Term Loans & Advances	64.80	67.67	128.19	120.63
Other Non Current Assets	177.61	25.40	25.93	28.52
Total Non-Current Assets	375.16	244.39	307.03	306.18
Currents Investments	290.90	1.80
Sundry Debtors	32.71	15.53	16.06	8.27
Cash and Bank	111.58	155.33	1.96	1.16
Other Current Assets	3.98	42.24	4.20	1,843.28
Short Term Loans and Advances	15.80	54.48	3.98	9.72
Total Current Assets	454.96	269.39	26.20	1,862.43
Net Current Assets (Including Current Investments)	276.02	4.33	-348.04	1,108.32
Total Assets	830.13	513.78	333.22	2,168.61
	83.57	83.57	84.80	84.74
Total Debt	0.05	47.00	258.19	556.14
	15.80	3.88	-6.69	41.25
Adjusted Book Value	15.80	3.88	-6.69	41.25

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	-222.58	-386.83	-342.78	1,553.01
Adjustment	6.99	-10.91	20.52	41.16
Changes In working Capital	141.11	-27.33	-46.86	-1,864.59
Cash Flow after changes in Working Capital	-74.48	-425.08	-369.12	-270.42
Cash Flow from Operating Activities	-69.12	-429.19	-360.29	-238.78
Cash Flow from Investing Activities	-548.28	391.53	157.66	-23.50
Cash Flow from Financing Activitie	616.76	42.41	199.26	261.39
Net Cash Inflow / Outflow	-0.64	4.74	-3.38	-0.89
Opening Cash & Cash Equivalents	1.22	0.58	5.33	1.96
Effect of Foreign Exchange Fluctuations		0.00	0.01	0.08
Closing Cash & Cash Equivalent	0.58	5.33	1.96	1.16

Ratios

Valuation

3.62

4.36

3.83

82.68

48.82

40.62

Profitability

276.89

163.94

124.17

85.08

82.65

Leverage & Liquidity

0.42

2.47

46.50

Returns

0.00

1.50

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67	65.67
	2.81	2.37	2.85	2.57	2.43	2.80	2.81	2.91	3.98	3.84
	31.52	31.96	31.48	31.76	31.89	31.53	31.52	31.42	30.34	30.49
	34.33	34.33	34.33	34.33	34.33	34.33	34.33	34.33	34.33	34.33
No. of Shareholders	1,25,184	1,28,205	1,31,034	1,42,864	1,40,724	1,36,997	1,44,810	1,40,625	1,41,957	1,41,992

Mutual Funds Invested(10)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 1 active fund holds 0.01% in Sun Pharma Advanced Research Company Ltd., contributing to ₹1 Cr of holdings

Fund				As of
MO Motilal Oswal Nifty Microcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	5.03	0.21	2,54,835	Sep '26
SA Samco Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	0.94	0.43	47,421	Sep '26
MO Motilal Oswal BSE Healthcare ETFIndex	0.05	0.12	2,622	Sep '26
IN Groww Nifty Total Market Index Fund - Growth - Direct PlanIndex Funds - Other	0.03	0.01	1,665	Sep '26
ID Bandhan BSE Healthcare Index Fund - Growth - Direct PlanIndex Funds - Other	0.02	0.12	1,236	Sep '26
MO Motilal Oswal BSE 1000 Index Fund - Growth - Direct PlanIndex Funds - Other	0.01	0.01	277	Sep '26
AO Angel One Nifty Total Market Index Fund - Growth - Direct PlanIndex Funds - Other	0.01	0.01	278	Sep '26
MI Mirae Asset Nifty Total Market Index Fund - Growth - Direct PlanIndex Funds - Other	0.00	0.01	229	Sep '26
ID Bandhan Nifty Total Market Index Fund - Growth - Direct PlanIndex Funds - Other	0.00	0.01	198	Sep '26
AO Angel One Nifty Total Market ETFIndex	0.00	0.01	194	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-22	Board Meeting	Quarterly Results
2026-08-03	Board Meeting	Quarterly Results
2026-07-06	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

Business ServicesBusiness Support

Sun Pharma Advanced Research Company Ltd. operates in the Business Services sector under the Business Support industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Kajal Damania

Company Secretary & Compliance Officer

—

Robert J Spiegel